Modafinil is a stimulant drug marketed as a ‘wakefulness promoting agent’ and is one of the stimulants used to treat narcolepsy. Narcolepsy is caused by dysfunction of a family of wakefulness-promoting and sleep-suppressing peptides, the orexins, whose neurons are activated by modafinil. The prexin neuron activation is associated with psychoactivation and euphoria. The exact mechanism of action is unclear, although in vitro studies have shown it to inhibit the reuptake of dopamine by binding to the dopamine reuptake pump, and lead to an increase in extracellular dopamine. Modafinil activates glutamatergic circuits while inhibiting GABA. It is grouped under the following drug class(es): Neurotransmitter agents, Psychotropic agents and Schedule IV controlled substances. Its therapeutic use is listed as ADHD agents and central nervous system (CNS) agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Provigil, Modiodal, modaphonil, Alertec and Sparlon. It is listed as a controlled drug substance (Schedule IV). Its PubChem CID is 4236.
Modafinil
| CAS No | 68693-11-8 |
|---|---|
| Molecular Formula | C15H15NO2S |
| Molecular Weight | 273.40 g/mol |
| Synonyms | 2-benzhydrylsulfinylacetamide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Modafinil is a stimulant drug marketed as a 'wakefulness promoting agent' and is one of the stimulants used to treat narcolepsy. Narcolepsy is caused by dysfunction of a family of wakefulness-promoting and sleep-suppressing peptides, the orexins, whose neurons are activated by modafinil.
The listed CAS number is 68693-11-8.
The listed molecular formula is C15H15NO2S.
The listed molecular weight is 273.40 g/mol.
2-benzhydrylsulfinylacetamide.
The source lists Provigil, Modiodal, modaphonil, Alertec and Sparlon.